TY - JOUR T1 - A single holiday was the turning point of the COVID-19 policy of Israel JF - medRxiv DO - 10.1101/2020.03.26.20044412 SP - 2020.03.26.20044412 AU - Ziv Klausner AU - Eyal Fattal AU - Eitan Hirsch AU - Shmuel C. Shapira Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/03/31/2020.03.26.20044412.abstract N2 - Background The impact of COVID-19 has been profound, and the public health challenge seem to be the most serious regarding respiratory viruses since the 1918 H1N1 influenza pandemic. In the absence of effective vaccine or biomedical treatment, the basic rules of public health measures have not changed, namely public distancing.Methods We analyzed epidemiological investigation reports during the first month of the outbreak in Israel. In addition, we present a deterministic compartment model and simulations of several scenarios emphasizing quarantine and isolation policies given their efficiency.Results We identify an abrupt change from controlled epidemic regime to an exponential growth (R0 = 2.19) in light of the actual policy-makers decisions and public behavior in Israel. Our analysis show that before the abrupt change, the new cases trend was due to returning citizens infected abroad. The abrupt change followed a holiday in which social distancing was clearly inefficient and many public gatherings were held. We further discuss three different modeled scenarios of quarantine efficiency: high-, medium-, and low-efficiency.Conclusions Israel early lessons show that there is no allowance to compromise with the directive of social distancing. Even before the onset of the pandemic in Israel, fine-tuned but determined early decisions were taken by policy makers to monitor flight arrivals from Covid-19 affected regions and to limit public gatherings. Our analysis show that one particular holiday has shifted the occurrence curve from controlled regime to exponential growth. Therefore, even a short lapse in public responsiveness can have a dramatic effect.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere is no external funding and there is no conflict of interest. The research was a part of the institutional research program on Covid-19.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesIsrael Ministry of Health. Information on confirmed patients and COVID-19 press releases. Accessed Mar 22, 2020. https://govextra.gov.il/ministry-of-health/corona/corona-virus/spokesman-messages-corona/ ER -